Alerts & notifications
-
Highly potent synthetic opioid detected in fake diazepam tabletNotification|06 May 2024
UPDATED 6 May 2024
A highly potent synthetic opioid, N-Desethyletonitazene, has been detected in a fake benzodiazepine tablets. -
Synthetic Cannabinoid misrepresented as DMTNotification|03 May 2024
UPDATED 3 May 2024
Synthetic Cannabinoid MDMB-4en-PINACA has been detected in a yellow powder presumed to be DMT -
Highly potent synthetic opioid misrepresented as butonitazeneNotification|03 November 2023
More highly potent nitazene variations have been identified.
-
Fake oxycodone tablets linked to serious harmNotification|27 September 2023
Fake oxycodone tablets, containing metonitazene, may be linked to a recent death and serious hospitalisations in New Zealand
-
Yellow tablet/powder containing potent opioid likely to cause serious harmNotification|21 October 2022
UPDATED 28 MARCH 2023
Serious harm has been identified in relation to metonitazene found in a yellow powder. High Alert urges continued caution, particularly in the Auckland region. -
Misrepresented MDMA linked to serious harm in Whanganui areaNotification|05 June 2022
An unknown brown powder being sold as MDMA has been linked to serious harm events in the Whanganui area.
-
AMB-FUBINACA detectedNotification|22 September 2020
The synthetic cannabinoid AMB-FUBINACA has been detected in a number of locations across New Zealand.
-
Synthetic cannabinoid MDMB-4en-PINACA detectedNotification|08 July 2020
High Alert has received information about the presence of MDMB-4en-PINACA, a synthetic cannabinoid that's an analogue of 5F-ADB.